[1]何斌 张冬颖.阿司匹林一级预防的研究进展[J].心血管病学进展,2020,(6):627.[doi:10.16806/j.cnki.issn.1004-3934.20.06.016]
　HE Bin,ZHANG Dongying.Primary Prevention of Aspirin[J].Advances in Cardiovascular Diseases,2020,(6):627.[doi:10.16806/j.cnki.issn.1004-3934.20.06.016]

点击复制

阿司匹林一级预防的研究进展()

分享到：

参考文献/References:

[1 ] U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events:recommendation and rationale[J]. Ann Intern Med,2002,136(2):157-160．

[2 ] Gaziano JM,Brotons C,Coppolecchia R,et al. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease(ARRIVE):a randomised, double-blind, placebo-controlled trial[J]. Lancet,2018,392(10152):1036-1046.

[3 ] Ridker PM . Should aspirin be used for primary prevention in the post-statin era?[J]. N Engl J Med,2018,379(16):1572-1574.

[4 ] 黄秋瑾 , 胡蓉. 高血压合并糖尿病患者血压控制率和控制目标的探讨[J]. 心血管病学进展,2019,40(7):973-976.

[5 ] Buse JB,Ginsberg HN,Bakris GL,et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus:a scientific statement From the American Heart Association and the American Diabetes Association[J]. Circulation,2007,115(1):114-126.

[6 ] Zalewska J. Acetylsalicylic acid does not prevent progression of primary circulatory disorders in patients without symptoms of arterial disease and diabetes—POPADAD trial[J]. Kardio Pol,2009,67(2):213-214.

[7 ] Hebert PR,Schneider WR , Hennekens CH . Use of aspirin among diabetics in the primary prevention of cardiovascular disease:need for reliable randomized evidence and astute clinical judgment[J]. J Gen Intern Med,2009,24(11):1248-1250.

[8 ] Younis N,Williams S,Soran H. Aspirin therapy and primary prevention of cardiovascular disease in diabetes mellitus[J]. Diabetes Obes Metab,2009,11(11):997-1000.

[9 ] Farkouh ME. ACP Journal Club.Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease[J]. Ann Intern Med,2009,150(2):JC1-8.

[10 ] ASCEND Study Collaborative Group,Bowman L,Mafham M,et al. Effects of aspirin for primary prevention in persons with diabetes mellitus[J]. N Engl J Med,2018,379(16):1529-1539.

[11 ] McNeil JJ,Wolfe R,Woods RL,et al. Effect of aspirin on cardiovascular events and bleeding in the healthy elderly[J]. N Engl J Med,2018,379(16):1509-1518.

[12 ] Ikeda Y,Shimada K,Teramoto T,et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors:a randomized clinical trial[J]. JAMA,2014,312(23):2510-2520.

[13 ] 程留芳. 老年上消化道出血临床特点及与药物相关性[C]. 中华医学会老年医学分会:中华医学会第四届全国老年消化专业学术会议论文集,2008:56-59.

[14 ] 陈夏欢,刘梅林,秦名芳,等.小剂量阿司匹林对老年人血小板聚集率的影响和短期安全性评估 : 一项多中心随机对照临床研究[J]. 中华高血压杂志,2019,27(9):900.

[15 ] 2019 阿司匹林在心血管疾病一级预防中的应用中国专家共识写作组. 2019阿司匹林在心血管疾病一级预防中的应用中国专家共识 [J/OL]. 中华心血管病杂志(网络版),2019,2:e1000020 (2019-08-19).

[16 ] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J]. 中国循环杂志,2019,34(3):209-220.

相似文献/References:

[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
　BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
　REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
　YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
　ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
　QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
　JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(6):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
　HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(6):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
　Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(6):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
　WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(6):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]